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ORIGINAL ARTICLE / ÖZGÜN ARAŞTIRMA
Effectiveness of sevoflurane or propofol combined with remifentanil for 
intubation without muscle relaxants
Kas gevşeticiler olmadan remifentanil ile kombine edilen sevofluran veya 
propofol ile entübasyonun etkinliği
Dilek Karaaslan, Tülay T. Peker, Pakize Kırdemir, Esra Nayır, Özlem Özorak, Hüseyin Kosat
Medical Faculty of Süleyman Demirel University, Department of Anesthesiology and Reanimation, Isparta-Turkey
ÖZET
Amaç: Bu çalışmada, kas gevşetici kullanılmadığında, se-
vofluran-remifentanil  kombinasyonunun  propofol-remi-
fentanil  kombinasyonuna  eşdeğer  düzeyde  entübasyon 
koşulları sağlayabileceği hipotezinin doğruluğunu araştır-
mayı amaçladık.
Gereç ve yöntem: Elektif cerrahi geçirecek ASA I-II gru-
bundan 80 hasta rastgele iki gruba ayrıldı. Grup I’deki has-
talara 1 mcg/kg/dk remifentanil infüzyonu ile %8 sevoflu-
ran inhalasyonu eş zamanlı olarak uygulandı. Grup II’deki 
hastalara 1mcg/kg/dk remifentanil ve 1 mg/kg/dk propo-
fol infüzyonu eş zamanlı olarak uygulandı. Bispektral in-
deks (BİS) değeri 60’ın altına düşer düşmez entübasyon 
girişimi uygulandı. Entübasyon koşulları çene gevşemesi, 
vokal kord açıklığı ve ekstremite hareketi kriterlerine göre 
optimal, iyi, sınırda ve zayıf olmak üzere değerlendirildi. 
Kalp hızı ve ortalama arter basıncı indüksiyondan önce, in-
düksiyon boyunca dakikada bir ve entübasyondan 1, 2 ve 
5 dk sonra kaydedildi. BİS değerinin 60’ın altına inmesine 
kadar geçen süre de kaydedildi.
Bulgular: Grup II’de (%90) grup I’e (%45) göre daha yük-
sek  oranda  hastada  optimal  entübasyon  koşulları  elde 
edildi (p=0.002). Başarılı entübasyon koşulları oranı grup 
I’de %80 iken, grup II’de %100 idi (p=0.035). Bispektral in-
deks değerinin 60’ın altına inmesi için geçen süre grup 
II’de (47.1±27.2 sn) grup I’e (111.9±60.6 sn) göre daha kısa 
idi (p=0.000). Kalp hızı ve ortalama arter basıncı her iki 
grupta da bazal değere göre düşüş gösterdi.
Sonuç: Bispektral indeks monitorizasyonu eşliğinde, pro-
pofol-remifentanil kombinasyonu sevofluran-remifentanil 
kombinasyonuna göre daha iyi entübasyon koşulları sağ-
lamış ve anestezi indüksiyonu süresini kısaltmıştır. Klin De-
ney Ar Derg 2011;2(2):138-43
Anahtar kelimeler: Entübasyon, kas gevşemesi, propofol, 
remifentanil, sevofluran
ABSTRACT
Objectives: We aimed to investigate the reliability of the 
hypothesis  that  whether  sevoflurane-remifentanil  could 
offer equivalent intubation conditions with propofol-re-
mifentanil in the absence of muscle relaxants.
Materials  and  methods:  Total  of  80  patients  of  ASA 
grades I and II scheduled for elective surgery were ran-
domly allocated into two groups. Patients in group I re-
ceived an infusion of remifentanil 1 mcg/kg/min and in-
halation of sevoflurane 8% until the Bispectral index (BIS) 
being less than 60. Patients in group II received a co-infu-
sion of remifentanil 1 mcg/kg/min and propofol 1 mg/kg/
min until BIS is <60. Intubation was attempted when BIS 
is <60. Intubation conditions were assessed as optimal, 
good, marginal, and poor using jaw relaxation, vocal cord 
opening, and limb movement. The heart rate and mean 
arterial blood pressure (ABP) were recorded before and 
during the induction, and thereafter, 1, 2 and 5 minutes 
following intubation. The time for BIS to be <60 was re-
corded.
Results:  Optimal  intubation  conditions  were  achieved 
more often in group II than in group I (90% versus 45%, 
p=0.002). The ratio of patients showing optimal or good 
intubating conditions was 80% in group I and 100% in 
group II (p=0.035). Time required for BIS to be <60 was 
shorter  in  group  II  than  in  group  I  (47.1±27.2  sec  vs. 
111.9±60.6 sec, p<0.001). In both groups, there was a de-
crease in heart rate and mean ABP compared to baseline.
Conclusion: Under BIS monitorization, propofol-remifen-
tanil  combination  offered  better  intubation  conditions 
and shorter anesthesia induction period compared with 
sevoflurane-remifentanil. J Clin Exp Invest 2011;2(2):138-
43
Key words: Intubating conditions, propofol, remifentanil, 
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INTRODUCTION
After induction of anesthesia, tracheal intubation is 
commonly facilitated by use of muscle relaxants. 
The concept of intubation without muscle relaxants 
finds its place in the situations where there is con-
traindication  to  both  depolarizing  (hyperkalemia, 
burns, plasma cholinestherase deficiency, penetrat-
ing eye injury) and nondepolarizing (myopathies, 
and known allergic reactions) neuromuscular block-
ing agents. It is also advantageous in cases where 
intubation is necessary but neuromuscular block is 
not required to facilitate surgical access.1,2
With an appropriate drug choice, the trachea can 
be successfully intubated without the use of muscle 
relaxants. Acceptable intubation conditions are ob-
tained with propofol accompanied by an opioid such 
as fentanyl, alfentanil, sufentanil or remifentanil.1-4 
On the other hand, high concentrations of sevoflu-
rane is frequently used for intubation without mus-
cle relaxants, mostly in children.5-7 It has been also 
used in adults alone or in combination with nitrous 
oxide for intubation without muscle relaxants.8 Joo 
et  al.9  used  sevoflurane-remifentanil  combination 
for intubation without muscle relaxants in adults. 
Proposed  advantages  of  sevoflurane  inhalational 
induction include lack of pain with drug injection 
and confirmation that the patient can be ventilated 
as anesthesia is induced.9
In this study, we aimed to investigate the reli-
ability of the hypothesis that whether sevoflurane-
remifentanil  combination  could  offer  equivalent 
intubation  conditions  with  propofol-remifentanil 
combination in the absence of muscle relaxants.
MATERIALS AND METHODS
After  obtaining  approval  from  Instutional  Ethics 
Committee and written informed consent from the 
patients, 80 patients of ASA grades I and II sched-
uled for elective surgery in Süleyman Demirel Uni-
versity hospital were included in the study. Patients 
with anticipated difficult intubation, increased risk 
of regurgitation, history of cardiorespiratory illness 
and known sensitivity to the drugs used were ex-
cluded from the study. Diazepam 10 mg po was used 
for premedication 2 hours prior to surgery. In the 
operating room, the baseline heart rate, and mean 
arterial pressure levels were recorded. Before induc-
tion of anesthesia, the patients inhaled oxygen for 5 
minutes (fresh gas flow 6 L/min) from a face mask 
connected to a semiclosed breathing circuit. The pa-
tients were randomly allocated into two groups by 
computer-generated table of random numbers.
Patients in group I received an infusion of re-
mifentanil 1 mcg/kg/min accompanied by a simulta-
neous inhalation of sevoflurane 8% (fresh gas flow 
was maintained at 6 L/min-1 oxygen, sevoflurane 
vaporizer was advanced at 8% setting to provide 
maximum sevoflurane delivery, the anesthetic cir-
cuit was filled with the anesthetic gas and the pa-
tient was asked to breathe normally through the face 
mask) until Bispectral index (BIS) becomes smaller 
than 60 during the induction of anesthesia. The pa-
tient was told that the anesthetic agent has a definite 
odor but would not be unpleasant to breathe.
Patients in group II received a co-infusion of 
remifentanil 1 mcg/kg/min and propofol 1 mg/kg/
min via two different venous access until BIS score 
becomes smaller than 60 during the induction of an-
esthesia.
As soon as BIS becomes smaller than 60, intu-
bation was attempted by an experienced anaesthe-
sist using a Macintosh 3 laryngoscope blade and an 
endotracheal tube 7.0 mm (for women) or 8.0 mm 
(for men).
The primary variables measured were condi-
tions for tracheal intubation and time for BIS to be 
<60.  Secondary  variables  measured  included:  1- 
heart rate, blood pressure, end-tidal CO2, end-tidal 
sevoflurane concentration (for group 1) at first, sec-
ond and third minutes of the induction; 2- degree of 
muscle rigidity during mask ventilation; 3- cough-
ing after intubation and after the inflation of endo-
tracheal tube cuff; and 4- postoperative sore throat.
Conditions  for  tracheal  intubation  were  as-
sessed according to jaw relaxation, vocal cord posi-
tion, and limb movement (Table 1). Hypoxemia was 
defined as SpO2 < 90%.
Table 1. Criteria for grading intubating conditions.
Intubating conditions Optimal Good Marginal Poor
Jaw relaxation Fully relaxed Partially relaxed Moderately stiff Severely stiff
Vocal cord opening Open Moving Closing Closed
Limb movement None Slight Moderate SevereD. Karaaslan et al. Intubation without muscle relaxants 140
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Degree of muscle rigidity during mask ventila-
tion was graded as: none-completely relaxed if no 
resistance to mask ventilation was felt; mild-mildly 
rigid if rigidity was felt by the operator but did not 
affect  manual  ventilation;  moderate-moderately 
rigid if ventilation was affected but ventilation was 
still possible; severe-fully rigid if muscle rigidity 
made positive pressure ventilation difficult.
Coughing at the intubation and after the cuff in-
flation, and postoperative sore throat were assessed 
using VRS (verbal rating score) (0: none, 1: mild, 2: 
moderate, 3: severe).
Following the intubation, in both groups the 
rate of remifentanil infusion remained unchanged 
while sevoflurane concentration was reduced to 2% 
in group II and the rate of propofol infusion was 
adjusted to 6 mg/kg/h for first 30 minutes.
Statistical analysis
The gender of the patients, the intubating condi-
tions quality, chest rigidity during mask ventilation, 
coughing at the intubation and after the cuff infla-
tion, and sore throat were compared between the 
two groups using chi-square test. The age, weight, 
height, heart rate, mean arterial pressure values, and 
time required for BIS to be smaller than 60 were 
compared between the groups using Mann Whit-
ney-U test. Heart rate and mean arterial pressure 
values were compared within the groups using Wil-
coxon Signed Ranks test. P<0.05 was considered 
statistically significant. A 30% difference in the suc-
cessful (optimal to good) intubating conditions be-
tween two groups was used in computing the power 
analysis (Minitab for Windows). Also, a type I error 
of 5% as well as a type II error of 20% were used in 
the power analysis. The results of the power analy-
sis indicated that a minimum of 33 patients were 
needed in each group. A P value of less than 0.05 
was accepted significant.
RESULTS
There were no differences in the demographic char-
acteristics between the groups (Table 2).
In both of the groups, there was a decrease in heart 
rate and mean arterial pressure compared to base-
line (Figures 1, 2). However, no patient developed a 
heart rate less than 45 beats/min. No patient needed 
atropine or efedrine. The heart rate, mean arterial 
pressure and SpO2 values showed no differences be-
tween two groups.
Figure 1. Heart rate (HR) with standard deviation.
*p<0.05  compared  with  basal  level  in  groups  1  and  2; 
□p<0.01 compared with basal level in groups 1 and 2
Figure  2.  Mean  arterial  pressure  (MAP)  with  standard 
deviation.
*p<0.05  compared  with  basal  level  in  groups  1  and  2; 
**p=0.000 compared with basal level in groups 1 and 2
Table 2. Patients demographics.
Sevoflurane+remifentanil (n=40) Propofol+remifentanil (n=40)
Age (year) 38.5±18.0 46.9±16.6
Weight (kg) 68.1±15.2 69.7±9.5
Height (cm) 165.3±7.9 167.3±5.9
Data are expressed as mean±standard deviationD. Karaaslan et al. Intubation without muscle relaxants 141
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Table 3. Induction and tracheal intubation.
Sevoflurane+remifentanil (n=40) Propofol+remifentanil (n=40)
Optimal intubating conditions
Good intubating conditions
Marginal intubating conditions
Poor intubating conditions
18 (45%)□
14 (35%)
8 (20%)
0
36 (90%)
4 (10%)
0
0
Hypoxemia during induction (SpO2 < 90%) 0 0
Muscle rigidity
                          -none
                          -mild
                          -moderate
                          -severe
32 (80%)
8 (20%)
0
0
34 (85%)
6 (15%)
0
0
Coughing after intubation
                          -none
                          -mild
                          -moderate
                          -severe
24 (60%)□
6 (15%)
10 (25%)
0
38 (95%)
2 (5%)
0
0
Coughing after cuff inflation
                          -none
                          -mild
                          -moderate
                          -severe
24 (60%)*
8 (20%)
8 (20%)
0
36 (90%)
2 (5%)
2 (5%)
0
Sore throat
                         -none
                         -mild
                         -moderate
                         -severe
28 (70%)
10 (25%)
2 (5%)
0
23 (57.5%)
15 (37.5%)
2 (5%)
0
Time for BIS < 60 (sec) 111.9±60.6** 47.1±27.2
Data are expressed as mean±standard deviation where appropriate. *p<0.05, □p<0.01, **p<0.001
Table 4. End-tidal CO2 concentration at the induction.
Sevoflurane+remifentanil (n=40) Propofol+remifentanil (n=40)
End-tidal CO2 at 1st min of induction 21.5±9.2 25.8±17.9
End-tidal CO2 at 2nd min of induction 24.2±8.1 33.2±20.3
Data are expressed as mean±standard deviation
Optimal  intubation  conditions  were  achieved 
more often in group II than in group I (90% ver-
sus 45%, p=0.002). The ratio of patients showing 
successful (optimal or good) intubating conditions 
was 80% in group I and 100% in group II (p=0.035) 
(Table 3).
All patients could be ventilated via a face mask 
after induction of anesthesia. No patient developed 
hypoxemia during the study period (Table 3). There 
were no complications during intubation. 
The incidence of muscle rigidity was similar 
between the two groups (Table 3).
The ratio of patients experiencing no cough at 
intubation was higher in group II than in group I 
(95% versus 60%, p=0.008), (Table 3).
The ratio of patients experiencing no cough af-
ter the cuff inflation was higher in group II than in 
group I (90% versus 60%, p=0.028), (Table 3).
The incidence of sore throat was similar be-
tween the two groups (Table 3).
Time required for BIS to be smaller than 60 was 
shorter in the group II than in group I (47.1±27.2 sec 
versus 111.9±60.6 sec, p=0.000) (Table 3).D. Karaaslan et al. Intubation without muscle relaxants 142
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End-tidal CO2 concentrations at the first and 
second minutes of the induction showed no differ-
ences between the groups (Table 4).
In group I, end-tidal sevoflurane concentration 
at the first, second and third minutes of the induction 
and 1 min after intubation were 4.8±2.0, 4.5±2.1% 
and 2.7±1.1% respectively.
DISCUSSION
In this study, Propofol offered successful intubating 
conditions in 100% of the patients within 47.1 sec-
onds while sevoflurane provided successful intubat-
ing conditions in 80% of the patients within 111.9 
seconds. No cough experience ratio was higher in 
propofol receiving patients than sevoflurane receiv-
ing patients. Propofol offered better intubating con-
ditions than sevoflurane and shortened the anesthe-
sia induction period.
We  used  BIS  monitorization  to  detect  anes-
thesia  depth  during  the  induction,  and  we  could 
intubate  patients  as  soon  as  BIS  became  smaller 
than 60. The monitorization of BIS shortened the 
anesthesia induction period compared to the previ-
ous  studies  using  propofol-remifentanil  combina-
tion for intubation without muscle relaxants.1,9-11 In 
these studies, the intubation was attempted at least 
90 seconds after the hypnotic administration. BIS 
monitorization was also used in the study conducted 
by Hanna et al., where the authors investigated the 
effects of rapid sequence propofol and remifentanil 
induction on intraocular pressure.12 They adminis-
tred remifentanil after the decrease of BIS below 60 
following propofol injection, and they performed 
the intubation 60 seconds after the administration of 
remifentanil. They obtained excellent or good intu-
bating conditions in 87% of the patients. As we used 
a simultaneous infusion of propofol and remifenta-
nil, we could succesfully intubate 100% of the pa-
tients after an apparently shorter induction period.
Propofol is suggested to be the agent of choice 
for intubation without muscle relaxants because of 
its significant myorelaxant properties on pharyngeal 
and laryngeal structures.13 Although sevoflurane has 
intrinsic muscle relaxant properties, we had better 
intubating conditions with propofol than sevoflu-
rane, and that made us think that propofol may have 
stronger laryngo-pharingeal myorelaxant effect than 
sevoflurane.9
Although  the  induction  of  anesthesia  with  a 
volatile agent is common in pediatric patients, sevo-
flurane’s low blood solubility in combination with 
its nonpungency makes possible mask induction of 
anesthesia in adults. In the present study, the end-
tidal sevoflurane concentration just before intuba-
tion was 4.47%, strongly higher than the concentra-
tion determined by Cros et al. (2.5%), but it is well 
comparable with the concentration determined by 
Joo et al. (4.3%).9,14 The mask end-tidal concentra-
tions of sevoflurane just before successful tracheal 
intubations were 5.6% and 5.1% for the sevoflurane/
oxygen  and  sevoflurane/nitrous  oxide  inhalations 
respectively.8 Kimura et al. determined MACei (en-
dotracheal intubation) for a 50% nonresponse to in-
tubation as 4.5%.15
Trabold et al. and Joo et al. suggested that in-
tubating conditions are better when remifentanil is 
injected after propofol, due to decreased risk of stiff 
chest and hypoventilation.9,16 In the present study, 
remifentanil was accompanied by a simultaneous 
infusion of propofol or an inhalation of sevoflurane. 
The ratio of patients showing no muscle rigidity 
was 70% and 85% for group I and II consecutively, 
while Joo et al. encountered no muscle rigidity in 
44% of their patients.9 The pretreatment with diaz-
epam and slow administration of remifentanil prob-
ably prevented muscle rigidity in the present study.
Higher number of patients with acceptable in-
tubation conditions are obtained by increasing the 
remifentanil dose. However, the higher dose of re-
mifentanil also results in a greater decrease in mean 
arterial pressure.9 Although remifentanil is associ-
ated with bradycardia or hypotension, or both in 
50%  of  healthy  patients  during  anesthetic  induc-
tion and intubation, its bradycardic effect can be 
avoided with the pretreatment with anticholinergic 
agents.10,17,18 We did not observe severe bradycardia 
in the absence of atropine pretreatment. It is prob-
ably related to shorter induction of anesthesia.
While  Mencke  et  al.  suggest  that  intubation 
without muscle relaxants may result in more lar-
ingeal damage, the results of the study conducted 
by Baillard et al. revealed no difference between 
intubation with and without muscle relaxants con-
cerning  postoperative  sore  throat  and  vocal  cord 
sequelae.19,20 Bouvet et al. highlighted that tracheal 
intubation  without  muscle  relaxants  may  be  effi-
ciently and safely performed when both large doses D. Karaaslan et al. Intubation without muscle relaxants 143
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of opioids and small endotracheal tubes are used.21 
We chose to use small endotracheal tubes (7.0 mm 
for women and 8.0 mm for men) in order to prevent 
laringeal damage. The ratio of patients free of sore 
throat was 70% and 57.5% respectively for sevoflu-
rane and propofol groups.
A limitation of the study is the impossibility of 
the blindness of the intubating anesthesist because 
of the residual smell of sevoflurane and white intra-
venous agent in the intravenous tubing.
In  conclusion,  under  BIS  monitorization, 
propofol-remifentanil  combination  offered  better 
intubation conditions than sevoflurane-remifentanil 
and shortened the anesthesia induction period.
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